Log in
Enquire now
‌

US Patent 12018257 Single-stranded RNA-editing oligonucleotides

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
1
Date Filed
April 6, 2023
1
Date of Patent
June 25, 2024
1
Patent Application Number
18296912
1
Patent Citations
‌
US Patent 8389703 Ribonucleoside analogs with novel hydrogen bonding patterns
1
‌
US Patent 8507663 Compositions and methods for inhibiting expression of CD274/PD-L1 gene
1
‌
US Patent 9650627 Site-directed RNA editing
1
‌
US Patent 9732347 Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
1
‌
US Patent 10676737 Targeted RNA editing
1
‌
US Patent 10941402 Chemically modified single-stranded RNA-editing oligonucleotides
1
‌
US Patent 10988763 Single-stranded RNA-editing oligonucleotides
1
‌
US Patent 11390865 Method for introducing site-directed RNA mutation, target editing guide RNA used in the method and target RNA-target editing guide RNA complex
1
‌
US Patent 11274300 Oligonucleotide complexes for use in RNA editing
1
‌
US Patent 11851656 Chemically modified single-stranded RNA-editing oligonucleotides
1
•••
Patent Inventor Names
Bart Klein
1
Petra Geziena De Bruijn
1
Roxana Simona Redis
1
Lenka Van Sint Fiet
1
Janne Juha Turunen
1
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
1
Patent Number
12018257
1
Patent Primary Examiner
‌
Sean McGarry
1

Find more entities like US Patent 12018257 Single-stranded RNA-editing oligonucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.